Invasive Group A Streptococcus Hypervirulent M1UK Clone, Canada, 2018-2023
- PMID: 39428565
- PMCID: PMC11521172
- DOI: 10.3201/eid3011.241068
Invasive Group A Streptococcus Hypervirulent M1UK Clone, Canada, 2018-2023
Abstract
To determine invasive group A Streptococcus trends in Canada, we characterized emm1 isolates collected during 2018-2023. The percentage of hypervirulent M1UK lineage isolates increased significantly, from 22.1% in 2018 to 60.2% in 2023. Genomic analysis identified geographically and temporally associated clusters and genes associated with virulent bacteriophage acquisition.
Keywords: Canada; M1UK; Streptococcus pyogenes; antimicrobial resistance; bacteria; emm1; group A Streptococcus; scarlet fever.
Figures
References
-
- Lynskey NN, Jauneikaite E, Li HK, Zhi X, Turner CE, Mosavie M, et al. Emergence of dominant toxigenic M1T1 Streptococcus pyogenes clone during increased scarlet fever activity in England: a population-based molecular epidemiological study. Lancet Infect Dis. 2019;19:1209–18. 10.1016/S1473-3099(19)30446-3 - DOI - PMC - PubMed
-
- World Health Organization. Disease outbreak news: increased incidence of scarlet fever and invasive group A Streptococcus infection—multi-country [cited 2023 Nov 26]. https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON429
-
- Pan American Health Organization/World Health Organization. Informative note: cases of diseases caused by group A Streptococcus in Uruguay [in Spanish] [cited 2023 Nov 28]. https://www.paho.org/es/documentos/nota-informativa-casos-enfermedades-c...
-
- Rodriguez-Ruiz JP, Lin Q, Lammens C, Smeesters PR, van Kleef-van Koeveringe S, Matheeussen V, et al. Increase in bloodstream infections caused by emm1 group A Streptococcus correlates with emergence of toxigenic M1UK, Belgium, May 2022 to August 2023. Euro Surveill. 2023;28:2300422. 10.2807/1560-7917.ES.2023.28.36.2300422 - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
